Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Shifting the Focus of pT1–2pN1 Breast Cancer: Are We Evaluating the Right Endpoint in Tailoring Adjuvant Radiation Therapy Recommendations?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. McGale P, Taylor C, et al. (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 383(9935):2127–2135.

    Article  Google Scholar 

  2. McBride A, Allen P, Woodward W, et al. Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment. Int J Radiat Oncol Biol Phys. 2014;89(2):392–398.

    Article  PubMed  Google Scholar 

  3. Poortmans PM, Collette S, Kirkove C, et al. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. The New England Journal of Medicine. 2015;373(4):317–327.

    Article  CAS  PubMed  Google Scholar 

  4. Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional nodal irradiation in early-stage breast cancer. The New England Journal of Medicine. 2015;373(4):307–316.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bazan JG, Majithia L, Quick AM, et al. Heterogeneity in outcomes of pathologic T1-2N1 breast cancer after mastectomy: looking beyond locoregional failure rates. Ann Surg Oncol. 2018;25:2288–2295.

    Article  PubMed  Google Scholar 

  6. Canadian Cancer Trials Group. Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer (TAILOR RT). ClinicalTrials.gov identifier NCT03488693. Available at: https://clinicaltrials.gov/ct2/show/NCT03488693. Accessed 24 Sept 2018.

Download references

Disclosures

Jose G. Bazan and Julia R. White have no conflicts of interest to disclose.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, James Cancer Hospital, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA

    Jose G. Bazan MD, MS & Julia R. White MD

Authors
  1. Jose G. Bazan MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julia R. White MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jose G. Bazan MD, MS.

Additional information

ASO Author Reflections is a brief invited commentary on the article, “Heterogeneity in Outcomes of Pathologic T1-2N1 Breast Cancer After Mastectomy: Looking Beyond Locoregional Failure Rates”, Ann Surg Oncol. 2018;25:2288–2295.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bazan, J.G., White, J.R. ASO Author Reflections: Shifting the Focus of pT1–2pN1 Breast Cancer: Are We Evaluating the Right Endpoint in Tailoring Adjuvant Radiation Therapy Recommendations?. Ann Surg Oncol 25 (Suppl 3), 681–682 (2018). https://doi.org/10.1245/s10434-018-6986-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-018-6986-4

Keywords

Search

Navigation